CGTLive’s Post

Listen to Dr. Salvador Rico, CMO of Encoded Therapeutics Inc., discuss the company's gene therapy and overall program looking to tackle #DravetSyndrome #InternationalEpilepsyDay Dravet Syndrome Foundation

Are you developing a cell or gene therapy? Make sure you start planning early for your long-term follow-up too! To learn more about the scientific and operational considerations to optimize your #LTFU, check out this white paper developed by me and Delphine Saragoussi, MD, MScPH #RWE #CGT #LTFU https://lnkd.in/eT7UNcWv

Headed to ASGCT this week? Stop by Booth #2235 to learn about our extensive commercial experience and regulatory track record to help advance your gene therapy to patients with more certainty. #ASGCT2024

There are many obstacles with managing the ancillary materials used in the production of cell and gene therapy products. In this webinar, sponsored by BioLegend, we discover the critical qualities of cytokines, growth factors, antibodies and culture media and risk-based strategies for assessing these challenges. Register now >>> https://hubs.ly/Q02HD5hk0

TOMORROW // Important considerations and challenges during the Investigational New Drug (IND) application process, with a focus on cell and gene therapy, here 👇 Live webinar | Register now: https://bit.ly/3TrVtbm

Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy

Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy

Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy

Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy

Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy